Clustering of other metabolic risk factors in subjects with metabolic syndrome

Metabolism: Clinical and Experimental

Volumn 59, Issue 5, 2010, Pages 697-702

  Hsieh, Shiun Dong ^a   Muto, Takashi ^b   Tsuji, Hiroshi ^a   Arase, Yasuji ^a   Murase, Toshio ^c  

^a TORANOMON HOSPITAL   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c Okinaka Memorial Institute for Medical Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; ISCHEMIC HEART DISEASE; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; SITTING; WAIST CIRCUMFERENCE;

CHOLESTEROL, HDL; FATTY LIVER; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; HYPERURICEMIA; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; RISK FACTORS; SEDENTARY LIFESTYLE; WAIST CIRCUMFERENCE;

EID: 77950608681     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.08.026     Document Type: Article

References (43)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
2. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112 (2005) 2735-2752
3. Alberti K.G., Zimmet P., Shaw J., et al. The metabolic syndrome. Lancet 366 (2005) 1059-1062
4. The Examination Committee for Criteria for "Obesity Disease" in Japan, Japan Society for the Study of Obesity. New criteria for "obesity disease" in Japan. Cir J 66 (2002) 987-992
5. Alberti K.G., Zimmet P., and Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23 (2006) 469-480
6. Smalley K.J., Knerr A.N., Kendrick Z.V., et al. Reassessment of body mass indices. Am J Clin Nutr 52 (1990) 405-408
7. Blair D., Habicht J.P., and Sims E.A. Evidences for an increased risk for hypertension with centrally located body fat and the effect of race and sex on this risk. Am J Epidemiol 119 (1984) 526-539
8. Kaplan N.M. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 149 (1989) 1514-1520
9. Hsieh S.D., and Yoshinaga H. Abdominal fat distribution and coronary heart disease risk factors in men-waist/height ratio as a simple and useful predictor. Int J Obes Relat Metab Disord 19 (1995) 585-589
10. Ashwell M., Lejeune S., and McPherson K. Ratio of waist circumference to height may be better indicator of need for weight management. BMJ 312 (1996) 377
11. Lin W.Y., Lee L.T., Chen C.Y., et al. Optimal cut-off values for obesity: using simple anthropometric indices to predict cardiovascular risk factors in Taiwan. Int J Obes Relat Metab Disord 26 (2002) 1232-1238
12. Ho S.Y., Lam T.H., Janus E.D., et al. Waist to stature ratio is more strongly associated with cardiovascular risk factors than other simple anthropometric indices. Ann Epidemiol 13 (2003) 683-691
13. Yan W., He B., Yao H., et al. Waist-to-height ratio is an accurate and easier index for evaluating obesity in children and adolescent. Obesity 15 (2007) 748-752
14. Lee C.M., Huxley R.R., Wildman R.P., et al. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol 61 (2008) 646-653
15. The Decoda Study Group. BMI compared with central obesity indicators in relation to diabetes and hypertension in Asians. Obesity 16 (2008) 1622-1635
16. Garnett G.P., Baur L.A., and Cowell C.T. Waist-to-height ratio: a simple option for determining excess central adiposity in young people. Int J Obes Relat Metab Disord 32 (2008) 1028-1030
17. He Y., Zhai F., Ma G., et al. Abdominal obesity and the prevalence of diabetes and intermediate hyperglycemia in Chinese adults. Public Health Nutr 6 (2008) 1-7
18. Nambiar S., Truby H., Abbott R.A., et al. Validating the waist-to-height ratio and developing centiles for use amongst children and adolescents. Acta Paediatrica 98 (2009) 148-152
19. Gelber R.P., Gaziano J.M., Orav E.J., et al. Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol 52 (2008) 605-615
20. Tseng C.H. Waist-to-height ratio and coronary artery disease in Taiwanese type 2 diabetic patients. Obesity 16 (2008) 2754-2759
21. Lin C.H., Chou C.Y., Lin C.C., et al. Waist-to-height ratio is the best index of obesity in association with chronic renal disease. Nutrition 23 (2007) 788-793
22. Lamacchia O., Pinnelis S., and Camarchio D. Waist-to-height ratio is the best anthropometric index in association with adverse cardiorenal outcome in type 2 diabetes mellitus patients. Am J Nephrol 29 (2009) 615-619
23. Hsieh S.D., Yoshinaga Y., Muto T., et al. Health risks among Japanese men with moderate body mass index. Int J Obes Relat Metab Disord 24 (2000) 358-362
24. Hsieh S.D., Yoshinaga H., and Muto T. Waist-to-height ratio, a simple and practical index for assessing central fat distribution and metabolic risk in Japanese men and women. Int J Obes Relat Metab Disord 27 (2003) 610-616
25. Hsieh S.D., and Muto T. The superiority of waist-to-height ratio as an anthropometric index to evaluate clustering of coronary risk factors among non-obese men and women. Prev Med 40 (2005) 216-220
26. Hsieh S.D., and Muto T. Metabolic syndrome in Japanese men and women with special reference to the anthropometric criteria for the assessment of obesity: proposal to use the waist-to-height ratio. Prev Med 42 (2006) 135-139
27. Hsieh S.D., Yoshinaga H., Muto T., et al. Regular physical activity and coronary risk factors in Japanese men. Circulation 97 (1998) 661-665
28. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
29. Japan Atherosclerosis Society. Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular disease 2007, in Japanese.
30. Sanyal A.J. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123 (2002) 1705-1725
31. Hamaguchi M., Kojima T., Takeda N., et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 143 (2005) 722-728
32. Wannamethee S.G., Shaper A.G., Lennon L., et al. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 28 (2005) 2913-2918
33. Ishizaka N., Ishizaka Y., and Toda E. Association between serum uric acid, metabolic syndrome and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 25 (2005) 1038-1044
34. Reaven G. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
35. Mohan V., Gokulakrishnan K., Deepa R., et al. Association of physical inactivity with components of metabolic syndrome and coronary artery disease-the Chennai Urban Population Study. Diabet Med 22 (2005) 1206-1211
36. Ford E.S., Kohl H.W., Mokdad A.H., et al. Sedentary behavior, physical activity, and the metabolic syndrome among US adults. Obes Res 13 (2005) 608-614
37. Avram Z., and Krishanan E. Hyperuricemia-where nephrology meets rheumatology. Rheumatology 47 (2008) 960-964
38. Choi H.K., and Curhan G. Independent impact of gout on mortality and risk of coronary heart disease. Circulation 116 (2007) 894-900
39. Paolicchi A., Edmin M., Ghliozeni E., et al. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation 109 (2004) 1440
40. Ruttmann E., Brant L.J., Concin H., et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality. Circulation 112 (2005) 2130-2137
41. Lieber C.S. Alcoholic fatty liver; its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 34 (2004) 9-19
42. Adams L.A., and Angulo P. Recent concepts in non-alcoholic fatty liver disease. Diabet Med 22 (2005) 1129-1133
43. Chen A.K., Robert C.K., and Barnard R.J. Effect of a short-term diet and exercise intervention on metabolic syndrome in overweight children. Metabolism 55 (2006) 871-878